Unique ID issued by UMIN | UMIN000022811 |
---|---|
Receipt number | R000026123 |
Scientific Title | Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients |
Date of disclosure of the study information | 2016/06/21 |
Last modified on | 2016/06/20 19:37:11 |
Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients
Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients
Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients
Randomized controlled trial of desflurane vs. sevoflurane in pediatric liver transplant patients
Japan |
Pediatric patients who are scheduled for living donor liver transplantation
Hepato-biliary-pancreatic surgery | Anesthesiology |
Malignancy
NO
To compare the effect of two inhalation antethstics, desflurane and sevoflurane, on the length of intubation in pediatric patients after living donor liver transplantation
Safety,Efficacy
Ratio of operating room extubation after pediatric living donor liver transplantation
1) Length of postoperative intubation
2) Length of Intensive care unit stay
3) Perioperative blood examination
4) Perioperative vital sign change
5) Perioperative infusion therapy volume
6) Perioperative urine output change
7) Ratio of postoperaitve infection
8) Ratio of postoperative rejection
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
2
Treatment
Medicine |
Anesthetic management with Desflurane
Anesthetic management with Sevoflurane
Not applicable |
16 | years-old | > |
Male and Female
1) patients who are scheduled for living donor liver transplantation at National Center for Child Health and Development, Tokyo, Japan; 2) patients weighted more than or equal to 6kg; 3) patients aged less than 16 years old; 4) patients whose informed consent is obtained from their guardians before operation
1) preoperative ICU management; 2) other organ complications caused by diseases other than the present liver illness; 3) allergy to either/both of inhalation anesthetic(s) or halogenated agents; 4) past history of malignant hyperthermia or family history of malignant hyperthermia; 5) metabolic disease; 6) acute liver failure; 7) pulmonary hypertension; 8) respiratory tract symptoms within 2 weeks before surgery; 9) asthma; 10) any cases inappropriate for the trial judged by surgeons or anesthesiologists in charge
65
1st name | |
Middle name | |
Last name | Chiaki Baba |
National Center for Child Health and Development
Anesthesia and ICU
2-10-1 Okura Setagaya Tokyo
0334160181
karaki-c@ncchd.go.jp
1st name | |
Middle name | |
Last name | Chiaki Baba |
National Center for Child Health and Development
Anesthesia and ICU
2-10-1 Okura Setagaya Tokyo
0334160181
karaki-c@ncchd.go.jp
National Center for Child Health and Development
None
Self funding
NO
独立行政法人国立成育医療研究センター
2016 | Year | 06 | Month | 21 | Day |
Unpublished
2016 | Year | 03 | Month | 15 | Day |
2016 | Year | 06 | Month | 22 | Day |
2016 | Year | 06 | Month | 20 | Day |
2016 | Year | 06 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026123